• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Dengue
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • Our story
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Dengue
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • Our story
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > News

Colombia has new diagnostic algorithm for the Chagas Disease Implementation Pilot Projects

Home > News

Colombia has new diagnostic algorithm for the Chagas Disease Implementation Pilot Projects

30 Nov 2016

The implementation Project for Chagas disease in Colombia is moving forward. After an epidemiological analysis, the partners confirmed the change of the diagnostic algorithm for the country’s pilot projects. With this new algorithm, positive cases for Chagas can now be confirmed by a simpler procedure test.

Colombia follows the serological recommendation of the World Health Organization (WHO) to confirm Chagas disease in the chronic phase by two tests, performing a third one in case of discordance. Thereby, to confirm the diagnosis of Chagas disease during the chronic phase, two tests are required. The current algorithm with indirect immunofluorescence as a confirmation diagnosis, is distinguished by its complexity, being a barrier to scale-up diagnosis and the following integral care of the infected, preventing this confirmation from being done at the primary level of care, close to the patients.

The change in diagnosis policy is part of the DNDi Pilot Project, which began in 2015 when several interest groups involved with Chagas disease joined a seminar in Bogotá to tackle barriers to diagnosis and treatment for Chagas.

As a starting point, a Healthcare Route was developed and regulated in order to simplify the processes and to transfer the responsibilities from a specialized level to the primary healthcare centers. This will be carried out by performing joint implementation of the pilot project, whose objective is to validate a model of care for Chagas disease.

Chagas in Colombia

  • 437,960 people are infected
  • 4,800,000 are at risk of infection

The Healthcare Roadmap

The Healthcare Roadmap attempts to eliminate the access barriers to treatment and drugs that are faced by population affected by this disease:

  1. Development of the Comprehensive Healthcare Route for chronic Chagas infection, signed in July by the Ministerial Resolution 3202, which formalizes its implementation.
  2. Validation and performance analysis of diagnosis commercial serological tests.
  3. Proposal of an alternative diagnostic algorithm for overcoming barriers in diagnostic confirmation.
  4. Elaboration of the Pilot Project of Healthcare Route for Chagas Disease in the four endemic municipalities.
  5. Development of a Capacity Building and Training Plan for the healthcare personnel working with Chagas at the Colombian Health System in the four endemic municipalities.
  6. Training of Colombian health professionals in collaboration with the Chagas Coalition and CEADES in Bolivia.

The pilot project is a cooperation between DNDi, the Ministry of Health and Social Protection, the National Institute of Health and the Departmental and Municipal Health Secretariats, funded by the Ministry of Health and Social Protection (Vector-Borne Disease Program) and the General System of Social Security in Health.

[Español] [Portuguese]

Policy advocacy Chagas disease

Read, watch, share

Loading...
Publications
17 Nov 2025

Open Science in a Closed World

News
17 Nov 2025

New DNDi report: Open science in a closed world – lessons and opportunities for securing openness and equitable access in R&D collaborations 

Statements
13 Nov 2025

Joint statement by CEPI, DNDi, MMV, and Unitaid on the Belém Health Action Plan (BHAP)

Press releases
10 Nov 2025

COP 30: The climate crisis is also a crisis for neglected diseases, warns DNDi

Press releases
4 Nov 2025

European Commission invests EUR 20 million to develop urgently-needed medicines against dengue in partnership with AFD and DNDi

Woman in rural village
Publications
29 Oct 2025

Chagas Platform Newsletter N°15

Jessica Robbins
Stories
24 Oct 2025

Jessica Robbins: A long and difficult journey with cutaneous leishmaniasis

Videos
24 Oct 2025

Road to Elimination of Kala-azar in South Asia

VIEW ALL

Help neglected patients

To date, we have delivered thirteen new treatments, saving millions of lives.

Our goal is to deliver 25 new treatments in our first 25 years. You can help us get there. 

GIVE NOW
Linkedin-in Instagram Twitter Facebook-f Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films, and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International license